183 related articles for article (PubMed ID: 28363822)
1. Lewis-Sumner syndrome in a patient with rheumatoid arthritis: Link between rheumatoid arthritis and demyelinating polyradiculoneuropathies.
Kedra J; Foltz V; Viala K; Tan S; Fautrel B
Joint Bone Spine; 2017 Jul; 84(4):485-487. PubMed ID: 28363822
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
3. Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis.
Hooper DR; Tarnopolsky MA; Baker SK
Muscle Nerve; 2008 Oct; 38(4):1318-25. PubMed ID: 18671292
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
Sanz PG; García Méndez CV; Cueto AL; Silva VB; Walther JC; Diez RA; Martins S; Giannaula RJ
Rheumatol Int; 2012 Dec; 32(12):4061-3. PubMed ID: 21922339
[TBL] [Abstract][Full Text] [Related]
5. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
6. [Chronic polyradiculoneuritis and its frontiers].
Vallat JM; Tabaraud F; Magy L; Macian F
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S27-31. PubMed ID: 12690658
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
Münch C; Anagnostou P; Meyer R; Haas J
J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating neuropathy after etanercept therapy in the course of juvenile idiopathic arthritis.
Genç HM; Kutlubay B; Sürmeli R; Sözen HG; Sözeri B
Turk J Pediatr; 2023; 65(1):165-169. PubMed ID: 36866999
[TBL] [Abstract][Full Text] [Related]
9. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
10. Hyperacute relapse of Lewis-Sumner syndrome during influenza A (H1N1) virus infection.
Ribeiro L; Monteiro A; Martins J
BMC Neurol; 2020 Nov; 20(1):427. PubMed ID: 33234123
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases.
Roux T; Debs R; Maisonobe T; Lenglet T; Delorme C; Louapre C; Leblond V; Viala K
J Peripher Nerv Syst; 2018 Dec; 23(4):235-240. PubMed ID: 30203907
[TBL] [Abstract][Full Text] [Related]
12. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
14. Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.
Giraud C; Tatar Z; Soubrier M
Clin Rheumatol; 2016 Oct; 35(10):2615-8. PubMed ID: 27541023
[TBL] [Abstract][Full Text] [Related]
15. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis: Biological therapy other than anti-TNF.
Rossi D; Modena V; Sciascia S; Roccatello D
Int Immunopharmacol; 2015 Aug; 27(2):185-8. PubMed ID: 25840282
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Bae SC
Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-induced remission in a woman with coexisting rheumatoid arthritis and nephrotic syndrome.
Weiss M; Gendelman O; Twig G; Tobar A; Amital H
Rheumatol Int; 2015 Sep; 35(9):1597-600. PubMed ID: 25578331
[TBL] [Abstract][Full Text] [Related]
20. Use of rituximab to treat a patient with coexistence of rheumatoid arthritis and ankylosing spondylitis: 18 months follow-up.
Dundar U; Çevik H; Demirdal US; Toktas H
Int J Rheum Dis; 2018 Oct; 21(10):1869-1872. PubMed ID: 24618052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
